WO1991018578A1 - Equipment to inactivate matrix at the fluidization therapy - Google Patents

Equipment to inactivate matrix at the fluidization therapy Download PDF

Info

Publication number
WO1991018578A1
WO1991018578A1 PCT/NL1991/000078 NL9100078W WO9118578A1 WO 1991018578 A1 WO1991018578 A1 WO 1991018578A1 NL 9100078 W NL9100078 W NL 9100078W WO 9118578 A1 WO9118578 A1 WO 9118578A1
Authority
WO
WIPO (PCT)
Prior art keywords
character
equipment according
equipment
patient
therapeutical
Prior art date
Application number
PCT/NL1991/000078
Other languages
French (fr)
Inventor
Victor George Ryhiner
Original Assignee
Reditac B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19857152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1991018578(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reditac B.V. filed Critical Reditac B.V.
Priority to DE69128523T priority Critical patent/DE69128523T2/en
Priority to EP91909550A priority patent/EP0496841B1/en
Publication of WO1991018578A1 publication Critical patent/WO1991018578A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61GTRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
    • A61G7/00Beds specially adapted for nursing; Devices for lifting patients or disabled persons
    • A61G7/05Parts, details or accessories of beds
    • A61G7/057Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor
    • A61G7/05738Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor with fluid-like particles, e.g. sand, mud, seeds, gel, beads
    • A61G7/05746Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor with fluid-like particles, e.g. sand, mud, seeds, gel, beads fluidised by air flow

Definitions

  • the invention relates to the basic principle derived from the air fluidization therapy as developed by Thomas S. Hargest and Artz. Studying this theme, Victor G.Ryhiner has further improved the fluidization therapy, as brought on the market at the moment by the name "Reda ⁇ tron Fluidized Therapy” and registered under patent nr.NL-8800792 premier depot 03-29-88 In this way it is already possible to extract moisture from one or more bodies.
  • the equipment is not being applied to therapeutical purposes only, but can also be used for industrial and/or agrarian products.
  • the principal aim is to treat patients with severe tissue deformation in the gradation from excematic to gangrenous deformation, therapeutically and sterile without the risk of contamination or crossinfection.
  • the optimum therapeutical depth by means of this equipment is reached at indication of burns 1-3 degrees, skin grafts and autograft ⁇ , intensive- and coronary care units, atrophy, geriatrics and many other applications, by which very vulnerable tissue is involved.
  • the equipment is based on the principle, by which the entering air, as well as the vapour tension coming from the absorbing raicrospheres , will be extracted from moisture continuously. Owing to this, an air entrance will occur which is ⁇ RH 40% at a temperature adjustable from 2 ⁇ °C (lower than the body temperature) to 38°C (higher than the body temperature),
  • SUBSTITUTE SHEET independent from the ambient temperature.
  • the viscosity is, also because of the low sg of the microspheres, 1.2 and brought in a fluidized state that could be compared with dry water with a RH ⁇ ⁇ 0%.
  • the body in its shape will be covered almost completely by the microspheres, which will benefit the therapy, also because of the subcapillary pressure of ⁇ 8mm/HG and the bubbling effect of the fluidized mass.
  • the dissipated heat from the condensing unit will be utilized at the demand for heating of the flotation medium, so that a re ⁇ ir ⁇ ulation of the dissipated heat will hardly influence the ambient temperature.
  • Therapeutical basin filled with 550 kg microspheres, in which the patient is treated and which is covered by a loose stretched polycon filtersheet or other comparable material with a permeability of 35 micron.
  • the therapeutical basin can also be filled with microspheres which have a hollow structure and if possible a diameter of lOO ⁇ and larger.
  • the operation of the invention is based on the following principle: (see figure 1).
  • the ambient air will, after passing the dustfilter Fl, pass the evaporator F2. Since the evaporator is brought to a temperature of 5°C, water- particles will be precipitated on the evaporator and will condensate.
  • the evaporator chamber F2 is connected with the vacuum chamber F3 by means of a reference leak.
  • the vacuum chamber F3 is connected to a vacuum pump or other venturi mechanism, in order to reach the desired underpressure. Causing an average vacuum pressure of 0,lmm/H20, the boilingpoint of the water will be lowered and atomized again into the ambient.
  • the air from which the water ⁇ particles have been extracted will be carried to a twostage air compressor FA, where it will reach a pressure .of 500ram/H20 under the fluidization compartment as installed in F5.
  • the hygrostat which has been installed will deactivate the condensing unit and evaporator, after the flotation material (microspheres) has reached the relative humidity degree of 35% (constant dehydration mode) .
  • the fluidization pressure of 500mm/H20 is enough to "boil" the mass ( ⁇ 550 kg microspheres) in the basin F5, with a viscosity of 1.0-1.2.
  • the airstreara will be a mixture of the ambient air together with the condensing di-ssipation by means of airvalve F7, which will be opened. With this a recirculation of the absorbed and dissipated ambient heat is reached.
  • basin F5 is adjustable in height from 65-85cm or from 80-100 ⁇ m, measured from the floor surface, by means of an electric- or otherwise applied lifting system.
  • the therapeutical basin is equipped with a molecular polyethylene fluidization sheet with a surface permeability of 5-20 ⁇ and a pressure drop of 20.5mBar (see figure 2 drawing C) .
  • a molecular polyethylene fluidization sheet with a surface permeability of 5-20 ⁇ and a pressure drop of 20.5mBar (see figure 2 drawing C) .
  • an equal and smooth fluidization is only possible at an absolute horizontal installation of the "njt see figure 2 drawing B) .
  • the fluidization will be equally shifted in a varied liquid and solid mass of the microspheres. With this not only an enclosure of the tissue as well as the body is reached, but a petrissage therapy will take effect, which will stimulate the circulation of the blood and reduce the pains, also as a result of the dehydration system.
  • the modulating rotation system of the basin is connected to the existing lifting system and can be adiusted in time values from 10-60 minutes by means of an electronic control.
  • the basin is held in a horizontal position of 90° (see figure 2 drawing B) .
  • the pulse therapy is built in as standard equipment, in order to eliminate sliding forces and traction formation as
  • the flotation material By reducing the fluidization pressure to the critical value of 250mm/H2O, the flotation material (microspheres) will remain air permeable and "mould" the body of the patient in a firm shape. By reducing the volume of the air compressor to 80M3 per hour, a reduction of the working pressure will be achieved. The temperature control as well as drain of moisture from the body will remain active. The electronic adjustment of the pulse therapy can be controlled in period intervals of 1-10 minutes passive and 1-10 seconds active.

Abstract

With the presence of a continuous dehydration device, the relative humidity degree of the air fluidized therapy will be as low as < 40 % to inactivate and to avoid culture of microorganisms. The application made the therapy accessible to all parts of the world, also those with a high humidity degree and temperature, to achieve optimum therapeutical depth for all tissue defects without risk of contamination or crossinfection, with an existing subcapillary closing pressure. To mobilize the patient, the unit has been adapted with a pulse and petrissage therapy, to modulate the enclosure of tissue and body with a remaining sequence of active dehydration and temperature control. For patient and nursing comfort, the therapeutical basin has been provided with an electric lifting system.

Description

EQUIPMENT TO INACTIVATE MATRIX AT THE FLUIDIZATION THERAPY
The invention relates to the basic principle derived from the air fluidization therapy as developed by Thomas S. Hargest and Artz. Studying this theme, Victor G.Ryhiner has further improved the fluidization therapy, as brought on the market at the moment by the name "Redaσtron Fluidized Therapy" and registered under patent nr.NL-8800792 premier depot 03-29-88 In this way it is already possible to extract moisture from one or more bodies.
However, in order to make the therapy completely accessible to all parts of the world, thus also those with a high humidity degree and temperature, it is necessary to reach a development, by which a continuous dehydration system will be present, so that, under all climatological circumstances, a relative humidity degree of the flotation medium of less than ά0% is reached. Besides, by means of a previous study on the behaviour of micro organisms, it has been confirmed that at a limit of RH 40%, no matrix is available for Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli.
The equipment is not being applied to therapeutical purposes only, but can also be used for industrial and/or agrarian products. The principal aim, however, is to treat patients with severe tissue deformation in the gradation from excematic to gangrenous deformation, therapeutically and sterile without the risk of contamination or crossinfection. The optimum therapeutical depth by means of this equipment, is reached at indication of burns 1-3 degrees, skin grafts and autograftβ, intensive- and coronary care units, atrophy, geriatrics and many other applications, by which very vulnerable tissue is involved. The equipment is based on the principle, by which the entering air, as well as the vapour tension coming from the absorbing raicrospheres , will be extracted from moisture continuously. Owing to this, an air entrance will occur which is < RH 40% at a temperature adjustable from 2έ°C (lower than the body temperature) to 38°C (higher than the body temperature),
SUBSTITUTE SHEET independent from the ambient temperature. The viscosity is, also because of the low sg of the microspheres, 1.2 and brought in a fluidized state that could be compared with dry water with a RH < ώ0%. The body in its shape, will be covered almost completely by the microspheres, which will benefit the therapy, also because of the subcapillary pressure of ± 8mm/HG and the bubbling effect of the fluidized mass. The dissipated heat from the condensing unit will be utilized at the demand for heating of the flotation medium, so that a reσirσulation of the dissipated heat will hardly influence the ambient temperature. At the same time, all moisture which will be extracted from the surroundings as well as the contents of the equipment, will be recirculated into the ambient, in this manner making the atmosphere where the patient is being treated, pleasant, as a result of a higher humidity. Also the ambient temperature will hardly increase.
The equipment of the invention could be devided into three main components: 1. An evaporator with a constant temperature of 5°C, connected to a vacuum condensing chamber and atomizer. The evaporator is controlled by a condensing unit consisting of a compressor part with a direct expansion, modulating and a tracking pressure, depending on the ambient temperature of 17°C to a maximum of 45°C. As coolant freon or substitute is applied. 2. The air chamber, supplied with a twostage compressor, to achieve the fluidization pressure (preferential pressure P=500mm/H20) . In the suctionline an airvalve has been adapted, which is controlled by a therraostatic device and is connected to the condensing chamber. 3. Therapeutical basin filled with 550 kg microspheres, in which the patient is treated and which is covered by a loose stretched polycon filtersheet or other comparable material with a permeability of 35 micron. The therapeutical basin can also be filled with microspheres which have a hollow structure and if possible a diameter of lOOμ and larger. By means of pressure
SUBSTITUTE SHEET adjustments with a differential pressure of at least P=200mm/ H20, an equivalent viscosity of the flotation medium will be obtained. The use of the microspheres with a hollow structure has as great benefit that the total weight of the microspheres will be decreased with a factor 5. Owing to this, the fluidization unit can be installed on wooden floors without support, consequently accessible for installation in every imaginable space.
The operation of the invention is based on the following principle: (see figure 1). The ambient air will, after passing the dustfilter Fl, pass the evaporator F2. Since the evaporator is brought to a temperature of 5°C, water- particles will be precipitated on the evaporator and will condensate. The evaporator chamber F2 is connected with the vacuum chamber F3 by means of a reference leak. The vacuum chamber F3 is connected to a vacuum pump or other venturi mechanism, in order to reach the desired underpressure. Causing an average vacuum pressure of 0,lmm/H20, the boilingpoint of the water will be lowered and atomized again into the ambient. After the air treatment, the air from which the water¬ particles have been extracted, will be carried to a twostage air compressor FA, where it will reach a pressure .of 500ram/H20 under the fluidization compartment as installed in F5. In this fluidization compartment the hygrostat which has been installed, will deactivate the condensing unit and evaporator, after the flotation material (microspheres) has reached the relative humidity degree of 35% (constant dehydration mode) . The fluidization pressure of 500mm/H20 is enough to "boil" the mass (± 550 kg microspheres) in the basin F5, with a viscosity of 1.0-1.2.
In case moisture is inserted in the absorbing microspheres, a vapour pressure will be created to the evaporator F2, which has a temperature of 5°C. This as a result of the second law of the thermodynamics. Here the vapour pressure will again condensate in waterparticles and drained into the vacuum
SUBSTITUTE SHEET - ά -
chamber. At the demand for heating of the flotation medium, the airstreara will be a mixture of the ambient air together with the condensing di-ssipation by means of airvalve F7, which will be opened. With this a recirculation of the absorbed and dissipated ambient heat is reached.
In order to simplify the nursing actions and to improve the patient's comfort, basin F5 is adjustable in height from 65-85cm or from 80-100σm, measured from the floor surface, by means of an electric- or otherwise applied lifting system. The therapeutical basin is equipped with a molecular polyethylene fluidization sheet with a surface permeability of 5-20μ and a pressure drop of 20.5mBar (see figure 2 drawing C) . Owing to the stiff behaviour of the polyethylene, an equal and smooth fluidization is only possible at an absolute horizontal installation of the "njt see figure 2 drawing B) . By modulating the installation of the basin within h degrees with regard to the horizontal situation (see figure 2 drawing A), the fluidization will be equally shifted in a varied liquid and solid mass of the microspheres. With this not only an enclosure of the tissue as well as the body is reached, but a petrissage therapy will take effect, which will stimulate the circulation of the blood and reduce the pains, also as a result of the dehydration system.
The modulating rotation system of the basin is connected to the existing lifting system and can be adiusted in time values from 10-60 minutes by means of an electronic control. At a constant fluidization therapy, the basin is held in a horizontal position of 90° (see figure 2 drawing B) .
By applying the molecular polyethylene fluidization board with a stiff behaviour, the carrying profile has been provided with a mechanical level adjustment (see figure 3 part A) With this is achieved that the fluidization pressure measured on each part of the body, will remain constant.
The pulse therapy is built in as standard equipment, in order to eliminate sliding forces and traction formation as
SUBSTITUTE SHEET much as possible.
By reducing the fluidization pressure to the critical value of 250mm/H2O, the flotation material (microspheres) will remain air permeable and "mould" the body of the patient in a firm shape. By reducing the volume of the air compressor to 80M3 per hour, a reduction of the working pressure will be achieved. The temperature control as well as drain of moisture from the body will remain active. The electronic adjustment of the pulse therapy can be controlled in period intervals of 1-10 minutes passive and 1-10 seconds active.
SUBSTITUTE SHEET

Claims

1. Equipment to constantly absorb moisture from the entering airstream, with the character that the application is based on a fluidization therapy to carry bodies in an absorbing microspheres mass . 2. Equipment to inactivate matrix, with the character to protect the therapeutical basin against micro organisms, avoiding contamination and crossinfection.
3. Equipment according to claims 1 and 2, with the character that the equipment is especially meant for patients with severe tissue deformation, wherein the patient is carried with an extremely low subcapillary pressure in an airpermeable and bubbling surface and by which the temperature can be adjusted according to requirements in the margins 26°C and 38°C and that, at a thermostatic demand for heating of the microspheres, the heat that has been released as a result of the direct expansion of the condensing unit, will be utilized, resulting in a recirculation of the absorbed and dissipated ambient heat. ά . Equipment according to claim 3, with the character that moisture derived from body exudates of the patient, will be drained to a condensing element, where it will be brought to boiling point in a vacuum chamber at a normal ambient temperature to be atomized again in the surroundings.
5. Equipment according to claim 1, with the character by which moisture is extracted from air and mass and which is supplied with a condensing unit and an evaporator, connected to a vacuum chamber by means of a reference leak, to be atomized hereafter in the ambient.
6. Equipment according to the previous claims, with the character by which the flotation medium partially consists of hollow microspheres, with a diameter preferable larger than lOOμ and a sg lower than 2.2.
7. Equipment according to claim 6, with the character that the beads are not solid, in order to achieve a lower sg per mass . 8. Equipment according to claim 3, with the character
SUBSTITUTE SHE that the therapeutical basin is provided with an electric- or other lifting system, in order to vary the lying level to the floor surface from 65-85σm or from 80-100cm.
9. Equipment according to all above mentioned claims, with the character that the applications will not only be limited to medical/therapeutical treatments, but will also be applied to bedsystems for domestic use.
10. Equipment according to all above mentioned claims, with the character that the basin can be modulated at an angle of 4° with regard to the horizontal level, in order to achieve an intermittently enclosure of body and tissue.
11. Equipment according to all above mentioned claims, with the character that the fluidization pressure can be reduced by means of an electronical a-synchronous multivibrator, in order to eliminate sliding forces and to mobilize the patient.
12. Equipment according to all above mentioned claims, with the character that the carrying profile has been provided with a mechanical level adjustment, in order to keep the smooth fluidization pressure on the body of the patient, as constant as possible.
SUBSTITUTE SHEET
PCT/NL1991/000078 1990-05-28 1991-05-07 Equipment to inactivate matrix at the fluidization therapy WO1991018578A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE69128523T DE69128523T2 (en) 1990-05-28 1991-05-07 EQUIPMENT FOR INACTIVATING THE BODY LAYER IN FLUIDIZATION THERAPY
EP91909550A EP0496841B1 (en) 1990-05-28 1991-05-07 Equipment to inactivate matrix at the fluidization therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9001211 1990-05-28
NL9001211A NL9001211A (en) 1990-05-28 1990-05-28 EQUIPMENT FOR INACTIVATING NUTRIENTS IN THE FLUIDIZATION THERAPY.

Publications (1)

Publication Number Publication Date
WO1991018578A1 true WO1991018578A1 (en) 1991-12-12

Family

ID=19857152

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL1991/000078 WO1991018578A1 (en) 1990-05-28 1991-05-07 Equipment to inactivate matrix at the fluidization therapy

Country Status (6)

Country Link
EP (1) EP0496841B1 (en)
AT (1) ATE161415T1 (en)
DE (1) DE69128523T2 (en)
ES (1) ES2110439T3 (en)
NL (1) NL9001211A (en)
WO (1) WO1991018578A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0621026A2 (en) * 1993-04-22 1994-10-26 Ssi Medical Services, Inc. Fluidized patient support with improved temperature control
US6073289A (en) * 1997-12-18 2000-06-13 Hill-Rom, Inc. Air fluidized bed
US6158070A (en) * 1999-08-27 2000-12-12 Hill-Rom, Inc. Coverlet for an air bed
US20140000039A1 (en) * 2012-06-27 2014-01-02 Frank Sauser Fluidizable Bed with Lateral Rotation Capability and Method of Operation Therefor

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449848A (en) * 1967-05-09 1968-01-15 J Werding Winfried Automatic swing bed
US3428973A (en) * 1966-03-17 1969-02-25 Thomas S Hargest Fluidized supporting apparatus
FR2546403A1 (en) * 1983-05-27 1984-11-30 Fuji Electric Co Ltd DEVICE FOR CONTROLLING THE MOVEMENTS FOR ELEVATION AND LOWERING OF A MEDICAL BED OF THE SAID FLUIDIZATION TYPE
FR2550442A1 (en) * 1983-05-27 1985-02-15 Fuji Electric Co Ltd Device for control of a fluidised bed for medical applications
US4694521A (en) * 1985-06-19 1987-09-22 Fuji Electric Co., Ltd Human body supporting device
US4768250A (en) * 1985-07-30 1988-09-06 Fuji Electric Co., Ltd. Fluidized bead bed
EP0332242A2 (en) * 1988-03-29 1989-09-13 Redactron B.V. Device for abstracting moisture and fluid from one or more bodies

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3428973A (en) * 1966-03-17 1969-02-25 Thomas S Hargest Fluidized supporting apparatus
CH449848A (en) * 1967-05-09 1968-01-15 J Werding Winfried Automatic swing bed
FR2546403A1 (en) * 1983-05-27 1984-11-30 Fuji Electric Co Ltd DEVICE FOR CONTROLLING THE MOVEMENTS FOR ELEVATION AND LOWERING OF A MEDICAL BED OF THE SAID FLUIDIZATION TYPE
FR2550442A1 (en) * 1983-05-27 1985-02-15 Fuji Electric Co Ltd Device for control of a fluidised bed for medical applications
US4694521A (en) * 1985-06-19 1987-09-22 Fuji Electric Co., Ltd Human body supporting device
US4768250A (en) * 1985-07-30 1988-09-06 Fuji Electric Co., Ltd. Fluidized bead bed
EP0332242A2 (en) * 1988-03-29 1989-09-13 Redactron B.V. Device for abstracting moisture and fluid from one or more bodies

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0621026A2 (en) * 1993-04-22 1994-10-26 Ssi Medical Services, Inc. Fluidized patient support with improved temperature control
EP0621026A3 (en) * 1993-04-22 1995-09-27 Ssi Medical Services Inc Fluidized patient support with improved temperature control.
US6073289A (en) * 1997-12-18 2000-06-13 Hill-Rom, Inc. Air fluidized bed
US6353948B1 (en) 1997-12-18 2002-03-12 Hill-Rom, Inc. Air fluidized bed
US6574813B2 (en) 1997-12-18 2003-06-10 Hill-Rom Services, Inc. Air fluidized bed
US6158070A (en) * 1999-08-27 2000-12-12 Hill-Rom, Inc. Coverlet for an air bed
US20140000039A1 (en) * 2012-06-27 2014-01-02 Frank Sauser Fluidizable Bed with Lateral Rotation Capability and Method of Operation Therefor
US9763842B2 (en) * 2012-06-27 2017-09-19 Hill-Rom Services, Inc. Fluidizable bed with lateral rotation capability and method of operation therefor

Also Published As

Publication number Publication date
DE69128523D1 (en) 1998-02-05
EP0496841B1 (en) 1997-12-29
DE69128523T2 (en) 1998-04-16
ATE161415T1 (en) 1998-01-15
ES2110439T3 (en) 1998-02-16
EP0496841A1 (en) 1992-08-05
NL9001211A (en) 1991-12-16

Similar Documents

Publication Publication Date Title
EP0332242B1 (en) Device for abstracting moisture and fluid from one or more bodies
US20220072288A1 (en) Medical treatment system and method of use
US8241258B2 (en) Wound treatment system and method of use
EP0688189B1 (en) Wound treatment employing reduced pressure
US7198046B1 (en) Wound treatment employing reduced pressure
US5179943A (en) Medical apparatus using ozone gas
WO1991018578A1 (en) Equipment to inactivate matrix at the fluidization therapy
CN104323897A (en) Medical suspending bed with double constant laminar flows
CN208975001U (en) A kind of micro- oxygen burn intelligence adjusting bin device of the infrared surface of a wound of temperature control wind-dryness
CN109045484A (en) A kind of infrared micro- oxygen surface of a wound burn intelligence adjusting bin device of temperature control wind-dryness
Scales et al. Levitation in the treatment of large-area burns
CN215021914U (en) Sand suspension treatment bed with red light
CN109481111A (en) A kind of burn laminar flow therapy apparatus
CN215740177U (en) Constant-temperature treatment table for dressing change of wound
KR100525286B1 (en) far-infrared ray generating device
Hargest Problems of patient support: the air fluidised bed as a solution
CN113018137A (en) Sand suspension treatment bed with red light
JPH01139506A (en) Processed dry flower
BG48346A1 (en) Method for treatment of sick persons with vast burnings
WO1995033431A1 (en) Improvements in or relating to beds
JPH0312105A (en) Storage type bed equipment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA SU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1991909550

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991909550

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1991909550

Country of ref document: EP